Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuanhuang Oral Liquid is a traditional Chinese medicine (TCM) developed and manufactured by Sichuan Sunnyhope Pharmaceutical. Formulated as an oral liquid, it is primarily indicated for the treatment of leucopenia (low white blood cell count) resulting from radiotherapy or chemotherapy. The preparation functions by replenishing qi, nourishing blood, and promoting the production of body fluids (nourishing yin). It is also used to address symptoms such as fatigue, dizziness, and dry mouth associated with weakened immune function following cancer treatments. As an exclusive TCM product, it is part of Sichuan Sunnyhope's core portfolio of approved medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chuanhuang Oral Liquid.